FDA Inspection 990107 — Taizhou Taifa Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Taizhou Taifa Pharmaceuticals Co., Ltd. on Sep 15, 2016 in Xianju, Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 15, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju, Taizhou (China)